SCHEMBL14060901

SCHEMBL14060901

FC(F)(F)c1[c]cc(-c2ccccc2Cl)cc1N1CCNCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 2/20 0.48
▸ HTR7 P34969 7/20 0.45
▸ HTR1A P08908 3/20 0.45
▸ HTR6 P50406 3/20 0.45
▸ HTR2A P28223 1/20 0.45
▸ HTR5A P47898 1/20 0.45
▸ CYP1A2 P05177 4/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ CYP2C19 P33261 3/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CLK4 Q9HAZ1 1/20 0.42
▸ DRD2 P14416 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ ADRB2 P07550 1/20 0.39
▸ CYP2D6 P10635 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27953728 0.87 ADRB1 (0.46) ADRB1HTR7HTR1AHTR6HTR2A
SCHEMBL27943377 0.81 ADRB1 (0.51) ADRB1HTR7HTR1AHTR6HTR2A
SCHEMBL27774299 0.69 ADRB1 (0.46) ADRB1HTR7HTR1AHTR6HTR2A
SCHEMBL27953737 0.68 ADRB1 (0.49) ADRB1HTR7HTR1AHTR6HTR2A
SCHEMBL27953748 0.68 CYP1A2 (0.46) CYP1A2CYP3A4CYP2C19LMNACLK4
SCHEMBL29446047 0.68 ADRB1 (1.00) ADRB1HTR7HTR1AHTR6HTR2A
SCHEMBL5785574 0.68 ADRB1 (1.00) ADRB1HTR7HTR1AHTR6HTR2A
SCHEMBL230424 0.68 ADRB1 (1.00) ADRB1HTR7HTR1AHTR6HTR2A
SCHEMBL13118662 0.67 HTR7 (0.69) ADRB1HTR7HTR1AHTR6HTR2A
SCHEMBL5566823 0.67 HTR7 (0.63) ADRB1HTR7HTR1AHTR6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103703005-A Tricyclic inhibitors of kinases ABBOTT LAB 2014-04-02 — — CN claimed
CN-103703005-A Tricyclic inhibitors of kinases ABBOTT LAB 2014-04-02 — — CN disclosed
EP-2681221-A1 TRICYCLIC INHIBITORS OF KINASES AbbVie Inc. (US) 2014-01-08 — — EP disclosed
WO-2012161812-A1 TRICYCLIC INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2012-11-29 — — WO disclosed
Send feedback